Connect with us

Cannabis News

when LPs stop keeping secrets

Published

1 month ago

on

On March 5, Innexo BV opened its research facilities in the Netherlands to more than 20 licensed producers from 10 countries for the first Acceleration Day 2026. The agenda covered two topics: Integrated Pest and Disease Management (IPDM) and Non-vegetable cropping strategies.

What Dominique van Gruisen, CEO of Innexo, did not expect was how much the room started talking. Producers from Germany, the Netherlands and further afield were comparing notes before the formal program began. “There’s no secret thing. ‘Hey, I’m doing this, this is working for me,'” Dominique said. “It was really special to see that interaction.”

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

It makes sense considering who was in the room. Most of these producers operate in different markets and are not in direct competition. “They realized that if they do a good job there is enough room for good players,” Dominique said. “Bad actors are the ones we have to worry about.”

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

No-veg: curiosity and operational reality
No-Veg definitely created the most buzz on the floor. In a no-veg system, the cuttings completely bypass the vegetative phase and go directly to a 12/12 flowering photoperiod, a strategy to shorten cycle times and reduce energy consumption, which is particularly important in the Northern European climate, where lighting and climate control dominate operating costs.

Dominique was frank about the state of No-Veg adoption: some producers had already implemented it after the conversation with Innexo, and said they would not back down; others were skeptical. The test room made the case better than any slide board. “We were doing different tests, different genetics and different conditions, they showed a lot of different scenarios at the same time,” he said. “The feedback I received was that it was one of the highlights of the event.”

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

Xavier G., founder of Avitas Global, who helped bring several international participants to the event, echoed this, and was grateful that Innexo did not oversell. “They showed the good, the bad and the ugly,” he said. “It makes sense to show the bad plants. It’s a research center. The plants need to see with their own eyes what can be done right and what can be done wrong. People were happy that they weren’t selling something perfect.”

IPDM: pest management as a facility architecture
The second major topic of the day was the case for a complete rethinking of pest and disease management as a design principle built into facility infrastructure from day one.

© Priscilla Heeffer | MMJDaily.com

Matthew Gates, a cannabis entomologist based in San Diego, gave a presentation entitled Cannabis Pest Strategy: Everswarm Evolution, developed in collaboration with Avitas Global. Matthew relied primarily on US-based cannabis pest research to map current and emerging threats, focusing on aphids, cutworms and powdery mildews, organisms he described as highly adaptable at the genetic and molecular level.

“Some selection pressures in one region will rapidly affect others,” Matthew said after the event, pointing to the global nature of pest resistance as a shared industry problem. “We all have to own it and move responsibly.” His presentation also addressed the risk of developing resistance to biocontrols and chemical interventions, and how common data sharing and proactive protocol design can prevent these pressures before they develop.

© Priscilla Heeffer | MMJDaily.com

Fluence’s Sabrina downplayed the two drivers of botrytis, osmotic pressure in the root zone, and faulty HVAC programming logic, both of which create VPD swings that create microclimates within the flowers where the pathogen thrives. The practical implication was that sensor data can identify botrytis risk before disease is seen, allowing growers to intervene earlier and more precisely. “He could have talked about Fluence products all the time,” said Xavier, “but he talked about LED and IPM. It sums up the vibe of the event.”

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

A platform built for collective progress
Acceleration Day also served as the official start of the next API cycle. The platform operates on three levels of participation. Innovators, who run five exclusive trials per year with full data access; Accelerators, which demonstrate technologies under greenhouse conditions; and Platformers, who tap into collective visions without large-scale testing. Entry-level participation starts at €10,000, a deliberate move to lower the barrier to the type of partnership that can move the industry faster than any single player.

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

Between 60 and 100 trials and demonstrations are planned in the next two years. Current partners include Fluence, FOHSE, Atami, Faven and ProGuard, among others. Atami is developing nutrient lines specifically for Non-Veg conditions; Faven is currently researching under-lighting in No-Veg environments; Fluence is studying spectral tuning across flower phases. Trials are conducted in parallel, in a working greenhouse, visible to all who visit the facility or attend an Acceleration Day. “It’s not like we’re renovating in a hidden bunker,” Dominique said. “This is for the betterment of the industry, for the betterment of LPs and ultimately for the benefit of patients.”

For Matthew, the event came in a place he didn’t expect. “The Innexo Acceleration Day connected me with a passionate and eclectic group of European professionals pushing the boundaries of cannabis research,” he wrote afterwards. “Real value comes from understanding critical aspects of cultivation and applying these findings to future planning, creating process excellence and competitive advantage.”

© Priscilla Heeffer | MMJDaily.com

© Priscilla Heeffer | MMJDaily.com

The next one is already on the calendar, June, the day before GreenTech Amsterdam, when international traffic to the Netherlands peaks. The focus will be genetics, confirmed Jorge Cervantes as speaker. If March is any indication, the conversations in the hallways can be just as important as what happens on stage.

For more information:
Innexo BV
(email protected)
LinkedIn
innexo.nl

Related Topics:
Continue Reading

Cannabis News

State hemp license applications end April 30

Published

19 hours ago

on

April 19, 2026

By











Those wishing to grow and process hemp this year must apply for a license from the Minnesota Department of Agriculture (MDA) by April 30. Each license is valid until December 31 of the year it is issued. Graduates must reapply annually to continue in the program. An MDA license is required for individuals and businesses.

So far, about 30 people have applied for the 2026 MDA license, compared to 84 applicants last year.

These licenses are for the cultivation and processing of industrial hemp only. The hemp license application is not for adult use or for growing or selling medical cannabis. The application is also not intended for the sale of hemp-derived cannabinoid products. Information on adult use and medical cannabis is available Office of Cannabis Management (OCM) website.

There are applications of industrial hemp MDA website. Along with the online form, first-time applicants and authorized representatives must submit fingerprints and pass a criminal background check.

There are also several updates for the 2026 season. The extraction of cannabinoids from hemp is now regulated by the OCM, meaning that anyone interested in this type of processing will need a separate licence. The rates have also changed. The base cost of a hemp license is now $400, with an additional $250 per growing or processing location. The previous $250 processor license fee has been removed, but a 5% surcharge now applies to upgrades to MDA’s technology systems.

All authorized representatives listed on an application must pass a background check before being licensed. In addition, each lot of hemp must undergo THC testing before harvest, and each official sample collected by the MDA costs $100.

Source: Minnesota Department of Agriculture










Continue Reading

Cannabis News

Colorado Marijuana Officials Announce Crackdown On Sales Of Hemp Products Amid ‘Risks To Public Safety’

Published

19 hours ago

on

April 18, 2026

By

These issues “pose serious risks to public safety, market integrity, and the tax revenue framework that supports Colorado’s regulated cannabis industry.”

By Christopher Osher, ProPublica and Evan Wyloge, The Denver Gazette

This story was originally published by ProPublica.

Colorado regulators announced Monday that they plan to crack down on companies that sell cheaper, potentially dangerous, illegal hemp products as marijuana.

The state’s Division of Marijuana Enforcement said it had identified “compliance issues” that threaten to dismantle the marijuana industry in the nation’s first legal retail market.

These problems “pose serious risks to public safety, market integrity and the tax revenue framework that supports Colorado’s regulated cannabis industry,” the agency said in an industry newsletter.

An investigation by the Denver Gazette and ProPublica in January reported that despite Colorado being one of the first states to ban the sale of intoxicating hemp products, the legislature and regulators. he failed adopting many of the rules that other states have used to keep hemp products off the medical marijuana shelves.

Creating evaporative and edible liquid distillate from hemp is much cheaper than using marijuana, giving companies a competitive advantage.

But regulators say they are concerned that manufacturers are relying on toxic and dangerous chemicals to convert the non-toxic CBD compound that is predominant in hemp into THC, the psychoactive compound that makes people feel high. Regulators have banned this chemical synthesis, saying they fear chemical residues could remain in the finished product, putting consumers at risk.

Colorado manufacturers have taken advantage of loopholes in the state’s testing and enforcement system to continue using hemp to make products marketed as marijuana, even though doing so is against state law, according to regulatory studies, previous agency bulletins and testimony and lab results contained in several lawsuits.

In 2024, state investigators found that a popular brand of marijuana sold at dispensaries was not only derived from hemp, but also contaminated with methylene chloride, the chemical often used to convert CBD from hemp into THC. Marijuana is banned by Colorado regulators and banned for most uses by the US Environmental Protection Agency because it can cause liver and lung cancer and damage the nervous, immune and reproductive systems.

Ware House, the company that manufactured these vaporizers, relinquished its marijuana license in response to the investigation. Ware Hause’s owner, Thanh Hau, and the company’s lawyer declined to comment.

Congress passed a law last November that bans nearly all hemp products nationwide starting this fall, but it’s unclear how the government will enforce the ban, and hemp growers are reeling.

In December, President Donald Trump issued an executive order telling his aides to work with Congress to develop rules that could allow certain hemp products.

The Colorado Division of Marijuana Enforcement made the announcement Monday newsletter agency officials stated that they “identified and investigated evidence” that marijuana companies are using illegal practices and prohibited methods to manufacture products, instead of relying on marijuana, which is supposed to be monitored for safety.

The Colorado Hemp Association and the Colorado Hemp Education Association did not immediately respond to requests for comment.

Beyond safety concerns, the bulletin also noted that some marijuana manufacturers and growers are avoiding marijuana tax obligations through “a pattern of non-compliance” in sales operations they report to the state’s “seed-to-sale” tracking system, which tracks marijuana from the initial planting to the sale of flower, vapes and other products at dispensaries.

Companies misrepresent marijuana sales at nominal prices, in some cases as low as $1 per pound for unprocessed marijuana material, the newsletter said. Those products typically fetch more than $600 per pound on the market, depending on the category of marijuana, according to industry experts.

That fraudulent reporting has stolen millions of dollars in marijuana taxes from state and local governments, industry experts say, though no official estimate is available.

The agency said it will follow emergency rules to address these issues. The bulletin emphasized that suspicious and abnormal transactions and inventories detected by the state will prompt investigations. Companies caught using hemp or other illegal material passed off as marijuana face “immediate product embargo, license suspension or revocation, significant fines and law enforcement,” regulators warned.

The Denver Gazette and ProPublica have tried to track the anomalous transactions, but the Division of Marijuana Enforcement’s sales transaction records, even those that do not identify the companies, are not public.

Marijuana industry representatives met with the division’s regulators late last month to push for a more aggressive response to the agency’s hemp replacement, even though it could affect some companies in the industry. The representatives argued that bad actors are unfairly driving down prices and shifting the tax burden to manufacturers and growers who are trying to comply with the rules. The newsletter was released a couple of weeks after that meeting.

“The division is also considering additional changes to its testing and screening protocols” to detect illegal products and prohibited methods, and may require additional laboratory tests “if needed for products throughout the supply chain,” the agency’s bulletin said.

This article was produced in partnership with ProPublica’s Local Reporting Network Denver Magazine. Sign up for Submissions to receive stories in your inbox every week.

user photo WeedPornDaily.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Nascent medical cannabis industry aims for growth

Published

2 days ago

on

April 18, 2026

By











The medicinal cannabis sector is struggling to take root, and another specialist processing plant is set to close. But with current regulations and a new collective industry in mind, New Zealanders are promising to reduce their reliance on imported medicinals.

There was great excitement when medicinal cannabis was legalized and then regulated in 2020, with the hope of growing the domestic sector and serving patients here and abroad. However, since then, several companies have closed their doors, including Greenfern Industries, Cannasouth and, most recently, Helius Therapeutics.

The latter plans to close the East Tāmaki plant, affecting 65 workers. It is one of the few medicinal cannabis factories in the entire nation that has a specialized processing certificate called “Good Manufacturing Practice” (GMP).

Medical Cannabis Council executive director Sally King said that under current rules, most growers did not have such certification, and could only sell raw ingredients, not processed products such as more profitable cannabis capsules.

Read more at the town










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media